Development of Therapeutic Agent for Osteoarthritis via Inhibition of KIAA1199 Activity: Effect of Ipriflavone In Vivo

This study aimed to clarify the effects of ipriflavone, which effectively reduces KIAA1199 activity, on osteoarthritis (OA) development and progression in an in vivo OA mouse model. The OA model mice were divided into the ipriflavone (200 mg/kg/day) group and the control group. OA onset and progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiarui, Nishida, Yoshihiro, Koike, Hiroshi, Zhuo, Lisheng, Ito, Kan, Ikuta, Kunihiro, Sakai, Tomohisa, Imagama, Shiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419624/
https://www.ncbi.nlm.nih.gov/pubmed/37569797
http://dx.doi.org/10.3390/ijms241512422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419624/
https://www.ncbi.nlm.nih.gov/pubmed/37569797
http://dx.doi.org/10.3390/ijms241512422

Ejemplares similares